Please read the following carefully prior to registering for our E-mail Alerts service by choosing to either Agree or Disagree.

If you select Agree, the E-mail Alerts registration form will be displayed. After entering the required fields, the E-mail Alerts containing our IR information will be sent to your registered e-mail address.

If you select Disagree, this service will not be provided.

Note on E-mail Alert:

Chugai Pharmaceutical (hereafter "Chugai") shall not be liable for any damages arising from errors or other inaccuracies in the information contained in the E-mail Alerts. (In particular, topics related to our future management strategies, operating policies and financial forecasts within the contents of E-mail Alerts are estimated based on assumptions and expectations in light of currently available information. These involve various risks and uncertainties including the economic conditions surrounding our company, the progress of research and development initiatives, and fundamental shifts in the securities market. Actual outcomes and results may materially differ from those expressed or implied in these statements.)

Chugai shall not be liable for any damages arising from the distribution or downloading of E-mail Alerts data. Chugai shall not be liable for any damages arising from security problems resulting from the transmission of e-mail messages, including incidents related to our e-mail transmissions being used to send camouflaged viruses.

If Chugai receives notification of delivery failure to your e-mail address, Chugai will not attempt to resend. If notification of delivery failure occurs more than ten times, your registered e-mail address may be deleted. Chugai accepts no liability for damages caused by the non-delivery of E-mail Alerts.

Chugai reserves the right to suspend or cease the operation of the E-mail Alert service at any time without notice to subscribers.

The information contained in E-mail Alerts constitutes neither an offer nor a recommendation to purchase or sell securities. Investors should apply their own judgment to any information before making any transaction decisions.

Even though the contents of E-mail Alerts or linked information may include information regarding pharmaceuticals (including products under development), the information is not intended as an advertisement and/or medical advice.

E-mail Alerts are sent to users with a registered subscription based on the user's own decision and through the Chugai website. Chugai will use subscribers' personal information, including registered e-mail address, for the purpose of providing our E-mail Alerts service or as an effective means of communicating to people interested in Chugai. Chugai will not disclose any personal information to any third party for any purpose without the subscriber's consent except when requested by legal authorities. However, to the extent necessary to accomplish the purposes described here, Chugai may provide subscriber information for the outsourcing company charged with managing its information services.

Please refer to the Website Privacy Policy.
Website Privacy Policy

Please contact the following regarding E-mail Alerts, disclosure, editing or canceling a registered e-mail address or any complaints.

Contact Information
  • Investor Relations Group
  • Corporate Communications Dept.
  • Tel: (0)3-3273-0554 (8:45 - 12:00, 13:00 - 17:30 excluding Saturdays, Sundays and holidays)
  • Fax: (0)3-3281-6607
  • ir@chugai-pharm.co.jp
  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top